Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Camurus

Biotech & Life Sciences · Lund Municipality, Sweden · Founded 1991 · IPO 2015 Unicorn

Developing and commercializing innovative and long-acting medicines

Valuation
$3.39B
Market cap · May/2026
Revenue
$274M
Latest reported FY
EBITDA
$140M
Latest reported FY

Investors

2 investors on Camurus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
Martin Gren
Erik Paulsson

Global footprint

Where Camurus has talent and traffic

Workforce by country
16 countries with
team presence
🇸🇪 Sweden58.9%
🇬🇧 United Kingdom8.3%
🇺🇸 United States7.2%
🇦🇺 Australia6.4%
🇩🇪 Germany6.2%
Top 5 of 16 shown
Web traffic by country
26K monthly visits
across markets
🇬🇧 United Kingdom28.1%
🇸🇪 Sweden25.4%
🇺🇸 United States18.8%
🇮🇳 India11.9%
🇨🇦 Canada5.4%
Top 5 markets shown

Patent intelligence

$53M patent portfolio · 23 active families

Estimated portfolio value
$53M
1.6% of market cap · 14.7× smaller than top peer BioNTech ($780M)
23 active patent families
Where Camurus innovates Active agentPharmacologyOrganic solventMedicinal chemistryLiquid crystalline

Where Camurus concentrates vs peers

Each axis is a top-10 topic across Camurus and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Camurus

An AI-synthesized read of the highest-engagement posts about Camurus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Camurus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.